Ideal for basic 12-lead resting ECG analysis, the MAC 3500 system delivers technology to help clinicians improve reliability and accuracy in cardiac assessments, while also helping to increase productivity and efficiency.

“The MAC 3500 is a great addition to our product line of electrocardiographs.  The ECG continues to be an important diagnostic tool for cardiovascular disease because of its ability to non-invasively identify the presence and severity of heart disease.  The ECG provides an efficient and cost-effective solution for caregivers spanning pre-hospital to hospital environments.  We are confident that clinicians will be pleased with the overall design, functionality, and utility of our new GE electrocardiograph to support them in their practice,” said Dr. Matthias Weber, vice president of GE Healthcare’s Diagnostic Cardiology business.

The MAC 3500 includes GE’s clinically proven Marquette ECG analysis programs:

• Marquette 12SL ECG simultaneous 12-lead ECG analysis program for adults and pediatrics – the industry’s most clinically validated program.
• Marquette Hookup Advisor™ signal quality analysis program, which reviews and measures ECG waveforms for signs of artifact and interference, helping to eliminate poor waveform quality during the recording of ECGs.
• Marquette® 12SL™ with Gender-Specific Interpretation that improves a clinician’s ability to detecting acute myocardial infarction (MI) in women.
An optional communications package with GE’s MUSE® cardiology information system helps streamline workflow and helps increase functionality. Barcode and magnetic card reader options help reduce errors and help improve workflow by automating data input and patient identification.